LINC01904

Across TCGA pan-cancer cohorts, LINC01904 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC01904 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01904 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01904 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ACC, STAD, and THCA are the cancer types where LINC01904 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.145	0.705	.002	72	view →
STAD	DFS	Tertile	All	0.177	0.408	.003	42	view →
THCA	DFS	Tertile	All	0.062	0.811	<.001	27	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	24	view →
KIRC	DFS	Tertile	IV	0.221	0.603	.046	18	view →
ESCA	OS	Tertile	III,IV	0.728	0.356	.034	18	view →
LIHC	OS	Tertile	All	0.565	0.785	.001	15	view →
OV	OS	Tertile	II,III,IV	0.194	0.327	.026	12	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC01904–ACC (OS)

Open the ACC breakdown →